Freenome

About Freenome

Freenome is a private biotech company focused on developing blood-based tests to detect cancer early and expand screening accessibility. The company combines multiomics science with artificial intelligence to identify early cancer signals from a standard blood draw, supporting proactive screening and early intervention. Based in Brisbane, California, Freenome pursues clinical programs and studies to validate its early-detection tests and advance cancer research.